D&O Ongoing Disclosure Notice

NZX^
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
Director or senior manager giving disclosure
To NZX Limited; and ASX
Name of listed issuer:
Oceania Healthcare Limited
Date this disclosure made:
3-Aug-26
Date of last disclosure:
24-May-24
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Full name(s):
Kathryn Elizabeth Waugh
Name of listed issuer:
Oceania Healthcare Limited
Name of related body corporate (if applicable):
N/A
Position held in listed issuer:
Chief Financial Officer
Class of affected quoted financial products:
Nature of the affected relevant interest(s):
Ordinary shares_________________
Registered and beneficial owner of
shares
For that relevant interest-______________________
Number held in class before acquisition or disposal:
Number held in class after acquisition or disposal:
Current registered holder(s):
Registered holder(s) once transfers are registered:
33,233
47,150
Kathryn Elizabeth Waugh
N/A
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
N/A
Class of underlying financial products:
N/A
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
N/A
Maturity date of the derivative (if any):
N/A
Expiry date of the derivative^ any):
N/A
The price specified in the terms of the derivative (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
N/A
For that derivative,-
Parties to the derivative:
N/A
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:N/A
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates:One

Details of transactions requiring disclosure-
Date of transaction:
Nature of transaction:
Name of any other party or parties to the transaction (if known):
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
Number of financial products to which the transaction related:
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
Date of the prior written clearance (if any):
Summary of other relevant Interests after acquisition or disposal:
Class of quoted financial products:
Nature of relevant interest:
For that relevant interest,-
Number held in class:
Current registered holder(s):
Fora derivative relevant interest,-
Type of derivative: I
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any);
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price's specified terms (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative relevant interest,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
28-JU1-26________________________
Issue of shares to Kathryn Waugh
upon vesting and exercise of
restricted share rights under
Oceania's restricted share right
scheme 2025 grant
N/A_____________________________
Nil______________________________
13,917__________________________
No
N/A_____________________________
N/A
Ordinary shares__________________
Beneficial interest in shares issued
under the terms of the Oceania
Employees Share Scheme
(a) 1,465 ordinary shares; and
(b) 1,060 ordinary shares subject to
restrictions
(a) CRS Nominees Limited
(b) OCA Employees Trustee Limited
| N/A_____________________________
N/A
N/A
N/A
N/A
_____________________________
N/A
N/A
N/A
N/A
Certification

I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.____________________________________________________
Signature of director or officer:
Date of signature:
or____________________________________________________________________________
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorised person:
3-Auq-26